| Entry |
Curated MiRNA |
Curated LncRNA |
Predicted MiRNA |
Predicted LncRNA |
| Record |
6 |
2 |
36 |
0 |
| Compound |
ncRNA |
Type |
Condition |
Link |
| Sirolimus |
GAS5-AS1 |
Curated lncRNA |
mantle cell lymphoma |
|
| Sirolimus |
GAS5-AS1 |
Curated lncRNA |
prostate cancer |
|
| Sirolimus |
hsa-miR-100-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-101-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-103a-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-107 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-1226-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-125b-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-128-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-130a-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-141-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-146b-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-148a-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-155-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-15b-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-16-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-17-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-181a-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-185-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-18a-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-18b-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-200a-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-200b-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-200c-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-203a |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-21-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-22-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-221-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-222-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-23a-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-27a-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-30a-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-30b-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-30c-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-362-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-374b-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-375 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-424-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-429 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-432-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-455-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-484 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-532-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-572 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-575 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-590-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-601 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-625-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-650 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-652-3p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-660-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-663a |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-7-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-760 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-765 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-770-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-874 |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-892b |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-9-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
hsa-miR-99a-5p |
predicted miRNA |
NCI60 |
|
| Sirolimus |
let-7 |
Curated miRNA |
brain tumour |
|
| Sirolimus |
miR-101 |
Curated miRNA |
osteosarcoma |
|
| Sirolimus |
miR-17 |
Curated miRNA |
brain tumour |
|
| Sirolimus |
miR-17-92 |
Curated miRNA |
brain tumour |
|
| Sirolimus |
miR-19 |
Curated miRNA |
brain tumour |
|
| Sirolimus |
miR-218 |
Curated miRNA |
cervical cancer |
|